Coastal Infusion Administers Humira®

Humira (adalimumab), currently the best-selling drug in the world, is a widely prescribed tumor necrosis factor (TNF) blocker used to treat a wide variety of conditions, including arthritis, ankylosing spondylitis, Crohn’s disease, psoriasis, hidradenitis suppurativa, and uveitis.

In these diseases, the body’s overproduction of TNF, a naturally occurring protein, may cause inflammation. The active substance in Humira, adalimumab, binds to TNF molecules and blocks them from attaching to healthy cells and attacking them. Humira does not stop the body from making too much TNF, but it is designed to reduce TNF’s damaging effects.

What It Treats

• Rheumatoid Arthritis (RA)
• Psoriatic Arthritis
• Polyarticular Juvenile Idiopathic Arthritis
• Crohn’s Disease and ulcerative colitis
• Ankylosing Spondylitis (AS)
• Plaque Psoriasis
• Hidradenitis Suppurativa
• Intermediate, Posterior, and Panuveitis Non-Infectious Uveitis

Prescribed By

Humira is most often prescribed by Rheumatologists, Gastroenterologists, Dermatologists, and Opthamologists.

How it’s Administered

Humira is administered by subcutaneous injection. Humira injections take only a few minutes.

Frequency

Humira is administered every other week after an induction dose (which can vary depending on the condition being treated).

Related Drugs

Avsola, Cimzia, Enbrel, Inflectra, Remicade, Renflexis, Simponi Aria

Additional Resources

• Humira Website
• Prescribing Information
• Co-Pay Assistance

The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies